Effect of Daily Intake of Gazpacho on Semen Quality and Oxidative Stress

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-45
SponsorGinefiv

About this trial

The goal of this clinical trial is to learn whether drinking a daily serving of gazpacho can improve semen quality in men with reduced sperm quality. The study will also examine how this dietary intervention affects oxidative stress and whether it is well tolerated.

The main questions this study aims to answer are:

* Does daily consumption of gazpacho improve semen quality in men with altered semen parameters? * Does this dietary intervention affect levels of oxidative stress in semen? * Is daily gazpacho intake feasible and well tolerated as part of a Mediterranean diet?

Researchers will compare a Mediterranean diet plus daily gazpacho intake with a Mediterranean diet alone to determine whether adding gazpacho provides additional benefits for male reproductive health.

Participants will:

* Follow a standardized Mediterranean diet for 12 weeks * Drink 330 mL of gazpacho every day or follow the diet without gazpacho * Provide semen samples at the start of the study and after 12 weeks * Complete a short diary to record adherence to the dietary intervention * Be followed for up to 18 months to record reproductive outcomes

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Men aged 18 to 45 years

Andrological profile including altered semen parameters such as oligozoospermia, asthenozoospermia and/or teratozoospermia (O±A±T)

No clinical indication for sperm DNA fragmentation testing or advanced sperm selection techniques

Willingness and ability to comply with the study protocol, including adherence to a standardized Mediterranean diet

Disqualifiers

Use of antioxidant supplements during the three months prior to study start.

Active smokers or men who have stopped smoking within the last three months.

Diagnosis of azoospermia, leucocytospermia or necrozoospermia.

Presence of severe systemic diseases or chronic conditions that could interfere with semen quality or adherence to the study.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Standardized Mediterranean Diet

    Other intervention

    Participants will follow a standardized Mediterranean diet for a period of 12 weeks. The dietary pattern emphasizes the consumption of vegetables, fruits, legumes, whole grains, olive oil as the main source of fat, moderate intake of fish and nuts, and limited intake of red and processed meats.

  • Gazpacho

    Dietary supplement

    Participants will consume 330 mL per day of commercially available gazpacho, taken once daily with a main meal, for a period of 12 weeks. The gazpacho will be consumed as part of the daily diet in addition to a standardized Mediterranean diet.

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: Standardized Mediterranean Diet Alone (Control)Active comparator 1 intervention
Group B: Gazpacho + Standardized Mediterranean Diet (Intervention)Experimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Change in Ejaculate Volume (mL)

Semen volume measured according to WHO 2021 semen analysis guidelines. This outcome will be analyzed and reported as an independent measure of semen quality. No composite or aggregated semen analysis score will be calculated; each parameter will be reported separately as a standalone outcome.

Time frame
Baseline to 12 weeks
2

Change in Sperm Concentration (million/mL)

Sperm concentration measured according to WHO 2021 semen analysis guidelines. This outcome will be analyzed and reported as an independent measure of semen quality. No composite or aggregated semen analysis score will be calculated; each parameter will be reported separately as a standalone outcome.

Time frame
Baseline to 12 weeks
3

Change in Total Sperm Motility (%)

Percentage of motile spermatozoa (total motility) assessed according to WHO 2021 semen analysis guidelines. This outcome will be analyzed and reported as an independent measure of semen quality. No composite or aggregated semen analysis score will be calculated; each parameter will be reported separately as a standalone outcome.

Time frame
Baseline to 12 weeks
4

Change in Progressive Sperm Motility (%)

Percentage of progressively motile spermatozoa assessed according to WHO 2021 semen analysis guidelines. This outcome will be analyzed and reported as an independent measure of semen quality. No composite or aggregated semen analysis score will be calculated; each parameter will be reported separately as a standalone outcome.

Time frame
Baseline to 12 weeks

Secondary outcomes

1

Change in Seminal Oxidative Stress Signal (Color Units, CU)

Seminal oxidative stress assessed using the OxiSperm II test based on a nitroblue tetrazolium (NBT) colorimetric reaction. The OXI II application provides a digital quantitative output expressed in Color Units (CU), ranging from 0 to 100 CU which will be reported as a continuous variable.

Time frame
Baseline to 12 weeks
2

Adherence to Gazpacho Intake (%)

Percentage of planned gazpacho intakes completed during the 12-week intervention period, assessed using a self-administered compliance diary and scheduled follow-up phone calls.

Time frame
Baseline to12 weeks
3

Incidence of Treatment-Emergent Adverse Events

Number and type of adverse events reported by participants during the 12-week dietary intervention period, assessed through participant self-report and scheduled follow-up phone calls.

Time frame
Baseline to 12 weeks
4

Biochemical Pregnancy Rate

Proportion of female partners with at least one positive serum or urinary hCG test during the follow-up period, calculated as the number of participants with a biochemical pregnancy divided by the total number of participants at risk.

Time frame
Up to 18 months post-intervention

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Ginefiv

Lead sponsor

Instituto Valenciano de Infertilidad, IVI VALENCIA

Collaborator